Krebs Andreas bought DFTX
September 18, 2026 · Form 4 insider transaction
Krebs Andreas bought 1,629 shares of Definium Therapeutics, Inc. at $35.52 per share, a transaction worth $57.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,629
Price
$35.52
Total value
$57.9K
InsiderKrebs Andreas
RoleDirector
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateSeptember 18, 2026
Filing dateSeptember 18, 2026
Shares owned after21,402
OwnershipDirect
10b5-1 planNo
AmendedNo